At least one person confirmed to have COVID-19 has died in North Korea and hundreds of thousands have shown fever symptoms, state media said on May 13, offering hints at the potentially dire scale of the country’s first confirmed outbreak of the pandemic.
Parkinson’s Foundation Announces Major Expansion of PD GENEration Study, Increasing Access to Genetic Testing and Counseling Across the U.S.
CNS Disorders, Gene Testing, Genetic Testing, Genomic Tests, Neurodegenerative Disorders, Parkinson's, Parkinson's Disease, Parkinson's Disease, Parkinson's Disease, Parkinson’s disease, Parkinson’s Disease, Parkinson’s disease, Parkinson’s disease, Personalization, Personalized Care, Personalized health, Personalized Medicine, Personalized TherapeuticsThe Parkinson’s Foundation has announced the expansion of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative offering genetic testing and counseling for people with Parkinson’s disease (PD) at no cost.
Roche sees slowdown in COVID-driven sales growth
Business, Business Intelligence, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Covid-19 antigen tests, COVID-19 Test Kits, COVID-19 Testing, Diagnostics, Earnings per share (EPS), Financials, Forecasts, Portable PCR COVID-19 Test Kits, Roche, Test Kits, TherapeuticsRoche’s first-quarter 2022 sales rose 10 percent on strong U.S. demand for rapid COVID-19 antigen tests and specialty drugs but the Swiss drugmaker reaffirmed that a drop in pandemic-related demand would put the brakes on growth.
Fentanyl overdoses are now the top cause of death among U.S. residents ages 18-45, surpassing suicide, car accidents and COVID, according to an analysis of federal data by opioid awareness organization Families Against Fentanyl. To prevent such deaths, FentCheck’s co-founders and a team of volunteers regularly visit a network of businesses in Oakland, San Francisco, New York and Philadelphia to replenish stocks of the test strips.
JScreen, a national non-profit public health initiative dedicated to preventing genetic diseases and hereditary cancer, educates communities across the United States on the importance of genetic screening for personal and family health. JScreen announced their support for National Cancer Control Month in April.
The U.S.Food and Drug Administration granted Emergency Use Authorization (EUA) for a breathalyzer that can detect COVID-19 within three minutes.
Pharmaceutical companies launch the Precision Cancer Consortium to drive global access to comprehensive genomic testing for all patients with cancer
Bayer, Biotechnology Companies, Biotechnology Companies, Diagnostic Tools, Diagnostics, Genomic Tests, GlaxoSmithKline, Novartis, Oncology, Pharma Companies, Precision Oncology, Roche, TherapeuticsThe Precision Cancer Consortium (PCC) announced its formation as a new collaboration of pharmaceutical companies with a shared vision of enabling access to comprehensive testing for all cancer patients globally.
White House faces April 18 deadline on transit mask mandate
Air travelers, Airline passengers, Airlines, Business, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Tests, COVID vaccine mandates, Covid-19 Airborne Transmission, COVID-19 Antibody Tests, Covid-19 antigen tests, COVID-19 Self Test, COVID-19 Testing, Covid-19 Virus, Joe Biden, White HouseThe Biden administration faces an April 18 deadline on whether to extend or end a mandate requiring travelers to wear masks on airplanes, trains and in transit hubs.
Genome sequencing group Illumina on March 15 launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.
White House readies roadmap for future COVID outbreaks, seeks funding
Antivirals, Business, Congress, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibody Tests, COVID-19 Deaths, Covid-19 Variants, Dr. Anthony Fauci (Director), Health Officials, Joe Biden, National Institute of Allergy and Infectious Diseases (NIAID), Outbreaks, Pandemics, Pharmacy, Reuters Analysis, SchoolsTop U.S. health officials on March 2 laid out a national blueprint to manage COVID-19 going forward, vowing to prepare for any new variant outbreaks without shutting down schools and businesses and calling for additional funding from Congress.